<DOC>
	<DOCNO>NCT00780039</DOCNO>
	<brief_summary>Doxorubicin use treat ovarian cancer part different combination therapy , high cumulative dos avoid risk cardiotoxicity . Pegylated Liposomal Doxorubicin ( Caelyx ) develop reduce risk cardiotoxicity . The purpose study evaluate safety efficacy Caelyx combination carboplatin woman recurrent ovarian cancer .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy Caelyx Combination With Carboplatin Patients With Ovarian Cancer Recurrent Within Six Twelve Months After Initial Carboplatin Paclitaxel Chemotherapy ( P03625 )</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Age &gt; =18 year old Subject must histological diagnosis epithelial ovarian cancer Subject must receive taxane platinum regimen maintain treatmentfree status least six month twelve month follow completion first line therapy . Subject must measurable ovarian cancer appropriate radiological imaging . ECOG performance Score 0 1 . Subject 's life expectancy must &gt; 6 month . Subject must normal organ function , except abnormal due tumor involvement : Adequate bone marrow function ( platelet &gt; =100 X 10^9/L , hemoglobin &gt; =100 g/L , neutrophils &gt; =1.5 X 10^9/L ) Adequate renal function ( serum creatinine &lt; =1.5 X upper limit normal ( ULN ) Adequate liver function ( bilirubin AST ALT &lt; =2 time ULN , unless relate primary disease . MUGA scan must indicate leave ventricular ejection fraction 90 % . Women childbearing potential must use adequate contraception ( prescribed medical supervision ) negative pregnancy test time enrollment . Subject must able sign write informed consent . Subject pregnant breast feeding . Subject history cardiac disease , New York Heart Association Class II great . Subject history severe hypersensitivity reaction product contain CremophorÂ® EL . Subject clinically significant hepatic disease . Subject uncontrolled bacterial , viral , fungal infection . Subject exhibit confusion disorientation . Subject condition would prevent adequate followup . Subject history prior malignancy treat systemic chemotherapy radiotherapy . Subject receive two prior chemotherapy regimens ovarian cancer .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>